Startup profile · funding coverage
OpenEvidence
AI medical search and clinical decision support for U.S. physicians.
Stage
growth
Status
private
Coverage
full
Why OpenEvidence is interesting
Fastest-growing physician app — a16z portfolio company whose rounds include Sequoia, Kleiner, Thrive, and Coatue across $300M+ raised at multi-billion valuations (2025–2026).
Key facts
- Series B (Jul 2025): $210M at $3.5B; GV and Kleiner co-led; Sequoia, Coatue, Thrive participated (PR Newswire)
- Series C/D (2025–2026): additional $200M–$250M rounds at rising valuations (Tech Startups, press)
- Co-investors not in VCT directory: Google Ventures, DST Global, Conviction, BOND, Craft Ventures
Investors in our directory
Funds linked from OpenEvidence's profile — open a fund page for stage focus and related deal articles.
Industries
Healthtech Enterprise SaaS
Industry hub pages are rolling out from our fund-derived baseline taxonomy.
FAQs about OpenEvidence
Funding context and why this company shows up in venture coverage.
OpenEvidence is listed among Andreessen Horowitz (a16z) investments on a16z’s public investment list.
We track a16z-backed companies that are strategically relevant for founders and investors following AI, American Dynamism, crypto, bio, and enterprise software.
Last updated: 2026-07-24